Filing Details
- Accession Number:
- 0001140361-11-013380
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-02 13:57:43
- Reporting Period:
- 2011-02-28
- Filing Date:
- 2011-03-02
- Accepted Time:
- 2011-03-02 13:57:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397144 | Llp Abingworth | Princes House 38 Jermyn Street London X0 SW1Y 6DN | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, 50 Pence Par Value Per Share | Disposition | 2011-02-28 | 275,000 | $7.92 | 16,725,000 | No | 4 | S | Indirect | See Notes |
Ordinary Shares, 50 Pence Par Value Per Share | Disposition | 2011-03-01 | 50,000 | $7.61 | 16,675,000 | No | 4 | S | Indirect | See Notes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Notes |
No | 4 | S | Indirect | See Notes |
Footnotes
- Abingworth LLP (the "Reporting Person") is the investment manager to a number of investment funds that include Abingworth Bioventures V L.P., Abingworth Bioventures V Co-Invest Growth Equity Fund LP and Abingworth Bioequities Master Fund Limited (collectively, the "Abingworth Funds"). The Reporting Person may be deemed to beneficially own the reported securities indirectly through the Abingworth Funds. The Abingworth Funds (i) sold an aggregate of 225,000 ordinary shares, 50 pence par value per share ("Ordinary Shares"), of Amarin Corporation plc (the "Issuer") on February 28, 2011, and (ii) sold an aggregate of 50,000 Ordinary Shares of the Issuer on March 1, 2011.
- The Reporting Person's interest in the securities reported herein is limited to the extent of its pecuniary interest in the Abingworth Funds, if any. This report shall not be deemed an admission that the Reporting Person, each Abingworth Fund or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.